Chromophores with large hyperpolarizabilities, films with electro-optic activity comprising the chromophores, and electro-optic devices comprising the chromophores are disclosed.

To provide an organosilicon compound having a cyclic silazane structure, represented by the following general formula (1): ##STR00001##
wherein R.sup.1 represents a hydrogen atom, an oxy radical, a hydroxyl group, a substituted or unsubstituted alkoxy group having 1 to 10 carbon atoms, or a substituted or unsubstituted monovalent hydrocarbon group having 1 to 10 carbon atoms, R.sup.2 represents a substituted or unsubstituted alkylene group having 3 to 6 carbon atoms, R.sup.3 and R each independently represent a substituted or unsubstituted monovalent hydrocarbon group having 1 to 10 carbon atoms, and n represents an integer of 0 to 2.

The present invention refers to silica particles functionalized with one or more silanes comprising a terminal group enabling a condensation reaction with the silica particles' surface, and at least one further terminal group for the modification of the silica particles' properties. The invention also relates to a process for the functionalization of silica particles by silanes, silanes as applied for the functionalization of the silica particles according to the invention, a process for the functionalization of silica by silanes, silica particles comprising a functional group, the use of the silica particles according to the invention, and coating compositions comprising the silica particles according to the invention.

A composition, and chemical vapor deposition method, is provided for producing a dielectric film. A gaseous reagent including the composition is introduced into the reaction chamber in which a substrate is provided. The gaseous reagent includes a silicon precursor that includes a silicon compound according to Formula I as defined herein. Energy is applied to the gaseous reagents in the reaction chamber to induce reaction of the gaseous reagents and to thereby deposit a film on the substrate. The film as deposited is suitable for its intended use without an optional additional cure step applied to the as-deposited film. A method for making the composition is also disclosed.

A cross-linked nucleoside of the present invention is a compound represented by the formula (I) below. The cross-linked nucleoside of the present invention is usable as a substitute for a phosphorothioate-modified nucleic acid, which has a risk of, for example, accumulation in a specific organ. The cross-linked nucleoside also has excellent industrial productivity.

##STR00001##

Disclosed herein are embodiments of a method for making substituted compounds with specific and selectable regiochemistry. Also disclosed are compounds made by the method. The method may comprise contacting a compound having a formula I

##STR00001##

with a compound according to formula II

##STR00002##

in the presence of a Lewis acid to form a phenol compound according to formula III and/or a benzofuranone compound according to formula IV

##STR00003##

Provided are a fluorine-containing ether compound that can form a surface layer that excels in durability and a method of manufacturing the same, a fluorine-containing ether composition and a coating liquid, and an article having a surface layer that excels in durability and a method of manufacturing the same. A fluorine-containing ether compound is expressed by the following formula (A1) or (A2):

{R.sup.fO—(R.sup.f1O).sub.m1—(R.sup.1).sub.m2—(CHF).sub.m3—O—(CHF).sub.m4}.sub.n1-Q.sup.1(-T.sup.1).sub.n2   Formula (A1)

(T.sup.2).sub.n3-Q.sup.2-(CHF).sub.m5—O—(CHF).sub.m6—(R.sup.2).sub.m7—O—(R.sup.f2O).sub.m8—(R.sup.3).sub.m9—(CHF).sub.m10—O—(CHF).sub.m11-Q.sup.3(-T.sup.3).sub.n4  Formula (A2), in the above, the symbols in the formulas are as described in the specification.

Described herein, inter alia, are Nurr1 receptor modulators and uses thereof. In an aspect is provided a method for treating a disease associated with dysregulation and/or degeneration of dopaminergic neurons in the central nervous system of a subject in need thereof, the method including administering to the subject in need thereof a therapeutically effective amount of a compound described herein.

A new and improved method for preparing maxacalcitol and an intermediate therefor is provided. The method is an efficient and cost-effective process for preparing maxacalcitol and an intermediate therefor.

Disclosed is a sulfur-containing silane compound for obtaining a cross-linked product which does not generate poor dispersion or adhesion between an organic polymer material and an inorganic material and exhibits excellent viscoelastic properties or adhesive properties, or a composition comprising the same. In particular, disclosed is a sulfur-containing silane compound represented by formula (1):

##STR00001##

wherein a, b, c, d, e, L, and each R group is as defined herein.